TY  - GEN
AU  - Kimijima,Izo
AU  - Tominaga,Takeshi
AU  - Nomizu,Tadashi
AU  - Nomura,Yasuo
AU  - Takashima,Shigemitsu
AU  - Koyama,Hiroki
AU  - Sano,Muneaki
AU  - Tohge,Tetsuya
AU  - Ueo,Hiroaki
AU  - Ikeda,Seiyo
AU  - Ohashi,Yasuo
TI  - [CGS20267 (Letrozole), a new aromatase inhibitor: late phase II study in postmenopausal women with advanced or recurrent breast cancer (no. 2)--evaluation of efficacy and safety at the recommended clinical dose CGS20267 Study Group]
SN  - 0385-0684
PY  - 2002///0611
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Aromatase Inhibitors
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Drug Administration Schedule
KW  - Enzyme Inhibitors
KW  - Estrogens
KW  - blood
KW  - Female
KW  - Humans
KW  - Letrozole
KW  - Middle Aged
KW  - Nitriles
KW  - Postmenopause
KW  - Survival Rate
KW  - Triazoles
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
ER  -